Patient Preferences for Communication of Life Expectancy in Prostate Cancer Treatment Consultations

JAMA Surg. 2022 Jan 1;157(1):70-72. doi: 10.1001/jamasurg.2021.5803.

Timothy J Daskivich^{1

2}, Rebecca Gale², Michael Luu³, Dmitry Khodyakov⁴, Jennifer T Anger⁵, Stephen J Freedland¹, Brennan Spiegel^{2

6}

¹ Division of Urology, Department of Surgery, Cedars-Sinai Medical Center, Los Angeles, California.
² Cedars-Sinai Center for Outcomes Research and Education (CS-CORE), Cedars-Sinai Medical Center, Los Angeles, California.
³ Department of Biostatistics, Cedars-Sinai Medical Center, Los Angeles, California.
⁴ RAND Institute, Santa Monica, California.
⁵ Department of Urology, University of California, San Diego, San Diego.
⁶ Division of Gastroenterology, Department of Medicine, Cedars-Sinai Medical Center, Los Angeles, California.

Abstract

This qualitative study examines patient preferences among men with prostate cancer for communications from clinicians about life expectancy.